← back to search

Tae Min Kim

Yeungnam University · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, and Lung Cancer Research Studies.
h-index
70
citations
21,762
works
758
NIH funding
primary concept
Medicine
email

Recent publications

Survival with Osimertinib plus Chemotherapy in <i>EGFR</i>-Mutated Advanced NSCLC.
2026cited by 16position: contributordoi
Limitations of the epcoritamab vs odronextamab comparative analysis.
2026cited by 1position: contributordoi
A spatially resolved human glioblastoma atlas reveals distinct cellular and molecular patterns of anatomical niches.
2026cited by 1position: contributordoi
Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies.
2026cited by 0position: contributordoi
Comparative Outcomes of Consolidation Strategies After R-MVP Induction in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
2026cited by 0position: contributordoi
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.
2026cited by 0position: contributordoi
Distribution and prognostic impact of LymphGen subtypes in Korean diffuse large B-cell lymphoma using clinical NGS panel.
2026cited by 0position: contributordoi
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.
2026cited by 0position: contributordoi
Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors.
2026cited by 0position: contributordoi
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanoma.
2026cited by 0position: contributordoi
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.
2026cited by 0position: contributordoi
Table S1 from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in <i>RET</i>-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026cited by 0position: contributordoi
Table S3 from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in <i>RET</i>-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026cited by 0position: contributordoi
Supplementary Table S4 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Figure S9 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Figure S3 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Figure S1 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Figure S11 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Figure S10 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Data from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in <i>RET</i>-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026cited by 0position: contributordoi
Supplementary Table S7 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Data from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in <i>RET</i>-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026cited by 0position: contributordoi
Supplementary Table S5 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Table S2 from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in <i>RET</i>-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026cited by 0position: contributordoi
Supplementary Table S3 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Figure S7 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Data from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Figure S2 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Table S8 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi
Supplementary Table S6 from Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
2026cited by 0position: contributordoi

Grants

Excellence in Research: Statistical Network Modeling and Inference for Complex Data
NSF2100729$783,4322021–2026PIRePORTER
The temperature of the circumgalactic and intergalatic medium over cosmic time
NSF2108702$392,2162021–2024PIRePORTER
Collaborative Research & GOALI: Direct-Fed Ethanol Metal-Supported Solid Oxide Fuel Cells
NSF2050824$233,4992021–2025PIRePORTER
Green chemistry degradation of cotton waste for circular economy textiles
NSF1948422$314,9982020–2023PIRePORTER
EAGER: Alternative Pathways for Biofuel formation from Furfuryl alcohol over Heterogeneous Catalysts
NSF1546647$112,0002015–2016PIRePORTER
Support for the Advances in Catalysis Symposium in the 2015 International Advances in Functional Materials Conference; Stony Brook, NY
NSF1546648$5,0002015–2016PIRePORTER
SBIR Phase I: Joining of Dissimilar Materials Using Rivet-Weld Technology
NSF1345675$179,0702014–2014PIRePORTER
NSF East Asia and Pacific Summer Institute for FY 2012 in Japan
NSF1210140$5,8362012–2013PIRePORTER
Mathematical Sciences: Domains of Holomorphy and Their Automorphisms
NSF9201019$35,0001992–1995PIRePORTER

Frequent collaborators

· 76 papers (2019–2026)Bhumsuk Keam · Cancer Research Institute20 papers (2019–2024)D.-W. Kim · Elsevier, Inc.18 papers (2020–2024)Yoon Kyung Jeon · Seoul National University18 papers (2024–2026) · 18 papers (2021–2024)Ja-Lok Ku · Seoul National University18 papers (2024–2026)Jaemoon Koh · Seoul National University Hospital17 papers (2024–2024)Doo Hyun Chung · Elsevier, Inc.17 papers (2024–2024)Dae Seog Heo · Seoul National University16 papers (2024–2024)Songji Oh · New Generation University College16 papers (2024–2024)Jeonghwan Youk · Seoul National University16 papers (2024–2024)Soyeon Kim · Seoul National University16 papers (2024–2024)Chul-Kee Park · Seoul National University Hospital10 papers (2019–2026)Sung-Hye Park · Seoul National University8 papers (2019–2026)Soon-Tae Lee · Teikyo University7 papers (2019–2026)Seung Hong Choi · National Cancer Center5 papers (2019–2022)Andrew McMillan · Nottingham University Hospitals NHS Trust5 papers (2018–2022)Matthew J. Matasar · Rutgers, The State University of New Jersey5 papers (2018–2024)Wojciech Jurczak · National Science Centre4 papers (2022–2024)Sang-We Kim · Université Grenoble Alpes4 papers (2019–2023)